Skip to main content

Find Clinical Trials

Home
Conditions
Fallopian Tube Cancer

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

335 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Completed

Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

NCT00702299

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Arizona Oncology - Scottsdale Scottsdale, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

NCT00031954

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Universitaetsklinikum Charite Berlin, Germany

Zentralkrankenhaus Bremen, Germany

Medizinische Klinik I Dresden, Germany

Evangelisches Krankenhaus Düsseldorf, Germany

View all 18 locations

View Trial Details

Completed

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

NCT00006454

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Universitaetsklinikum Charite Berlin, Germany

Universitaetskliniken Bonn Bonn, Germany

Zentralkrankenhaus Bremen, Germany

Medizinische Klinik I Dresden, Germany

View all 19 locations

View Trial Details

Completed

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

NCT00390234

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +30 more
Locations: City of Hope Duarte, California, United States

University of Southern California Los Angeles, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View all 16 locations

View Trial Details

Completed

Interactive Educational Website for Women With Ovarian Cancer & Caregivers

NCT01626014

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

NCT00059787

Conditions: Adnexal Diseases, Brenner Tumor, Carcinoma, +31 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

NCT01091259

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Bellevue Hospital Center (NYU Langone Medical Center affiliate) New York, United States

New York University Clinical Cancer Center New York, United States

View Trial Details

Completed

AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00275028

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

NCT01253681

Conditions: Adnexal Diseases, Carcinoma, Endocrine Gland Neoplasms, +20 more
Locations: Research Site Footscray, Victoria, Australia

Research Site Malvern, Victoria, Australia

Research Site Parkville, Victoria, Australia

Research Site Brussels, Belgium

View Trial Details

Completed

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

NCT00770536

Conditions: Adnexal Diseases, Cancer, Carcinoma, +29 more
Locations: Research Site Tucson, Arizona, United States

Research Site Sacramento, California, United States

Research Site Orlando, Florida, United States

Research Site Tampa, Florida, United States

View all 16 locations

View Trial Details